Listing - March 27, 2017
Targovax moves share listing to Oslo Børs
Targovax announces that its shares have been accepted to list on Oslo Børs, the main Oslo Stock Exchange. The company was previously listed on Oslo Axess, a regulated and licensed market under the auspices of the Oslo Stock Exchange. “This move marks another exciting step for Targovax. Being part of the main market is an […]
Listing - February 8, 2017
Oncopeptides announce listing of its shares on Nasdaq
Oncopeptides has, together with HealthCap and Industrifonden (together the “Main Shareholders”), decided to, in order to further the company’s continued development of its product candidate Ygalo, carry out a broadening of its shareholder base through a new share issue of SEK 650 million (the “Offering”). The Board of Directors of Oncopeptides has applied for a […]
Listing - November 29, 2016
Trading of Alligator on Nasdaq has begun
Alligator Bioscience has started trading of its shares on the main market of Nasdaq Stockholm. Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies and is primarily active in the early phases of drug development, from the idea stage to clinical phase II trials. […]
Listing - November 16, 2016
Acarix to Nasdaq First North
Acarix applies for entry on Nasdaq First North Premier in Stockholm. The capital contribution which the company pertain to obtain in connection to the entry is worth 140 million SEK, already secured through description and garantee undertakings. The capital from the entry will mainly go to the company’s commercialization strategy and their planned launch of […]
Biotech Business - November 13, 2016
PCI Biotech with share issue in November
PCI Biotech has initiated a process with the objective to carry out a share issue in the range of NOK 40-50 million by the end of November 2016. Two of the largest shareholders have pledged that they will at least follow up their pro-rata in the share issue. Fondsfinans is retained as advisors in this […]
Listing - June 22, 2016
AroCell apply for listing on Nasdaq
The Board of Directors of AroCell AB have decided to apply for listing of the company shares to trading on the Nasdaq First North exchange, and thereby change market for share listing. The change of market listing is planned to take place at the turn of the month June/July 2016, and the first date for […]
